Search

Displaying results 7811 - 7820 of 10000 in total
  1. Drug

    Go-6976

    go.drugbank.com/drugs/DB17029
    Experimental

    An inhibitor of calcium-dependent isoforms of protein kinase C.[A253002,A253007]

  2. Drug

    N-oleoyldopamine

    go.drugbank.com/drugs/DB17036
    Experimental

    N-oleoyldopamine (OLDA) is an amide of dopamine and oleic acid.[A253042]

    Synonyms: N-oleoyldopamine, (9z)- n-(2-(3,4-dihydroxyphenyl)ethyl)-9-octadecenamide
  3. Drug

    PI-103

    go.drugbank.com/drugs/DB17046
    Experimental

    PI-103 is an inhibitor of p110α of class I PI3K.[A253092]

  4. Drug

    SRT-1720

    go.drugbank.com/drugs/DB17057
    Experimental

    SRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.[A253147]

    Synonyms: 2-quinoxalinecarboxamide, n-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-, N-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamide
  5. Drug

    Edralbrutinib

    go.drugbank.com/drugs/DB18095
    Investigational

    Edralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.

  6. Drug

    VCN-01

    go.drugbank.com/drugs/DB18193
    Investigational

    VCN-01 is an investigational, genetically modified human adenovirus encoding human PH20.

  7. Drug

    Acediasulfone

    go.drugbank.com/drugs/DB08926
    Experimental

    Acediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.

  8. Drug

    Vofatamab

    go.drugbank.com/drugs/DB14781
    Investigational

    Vofatamab is under investigation in clinical trial NCT02401542 (Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma).

  9. Drug

    PF-04634817

    go.drugbank.com/drugs/DB14955
    Investigational

    PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).

  10. Drug

    Gremubamab

    go.drugbank.com/drugs/DB15014
    Investigational

    Gremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).